Boardwalktech Software Corp has completed a private placement, raising approximately C$874,500 by issuing 17.49 million units at C$0.05 each. Each unit includes one common share and one warrant exercisable at C$0.06 for two years. The funds will be used for general corporate purposes, pending final approval from the TSX Venture Exchange. This financing supports Boardwalktech's continued development of its patented digital ledger and AI enterprise software solutions.
Boardwalktech's recent private placement is presented here with a snapshot of the Technology sector on Pluang as of Sep 24, 2026 16:51 WIB. Among 150 priced US tech stocks, only 16 rose while 127 fell. For example, AXTI dropped 4.55% to USD 69.66 with a balanced 50% sell and 50% buy order activity, CRDO declined 4.06% to USD 186.00 with 71% sell orders, whereas YOU gained 3.93% to USD 40.43 with 100% buy orders and a typical hold time of 17 days.
XRP showed a potential bullish inverse head-and-shoulders pattern with a key resistance neckline near $1.57 and further resistance around $1.60. A decisive and sustained break above these levels is needed to strengthen the bullish case and target $2....
Google announced a new initiative partnering with veterans organizations to help 25,000 veterans, service members, and military spouses enter skilled trades. This effort addresses a nationwide shortage of skilled trade workers driven by increased dem...
OS Therapies announced that the World Health Organization has approved 'Herlystic' as the brand name for its gene-edited cancer immunotherapy OST-HER2. With both the proprietary and nonproprietary names approved, the company is set to begin regulator...
XRP climbed from around $1.27 to test resistance between $1.61 and $1.70 but faced selling pressure that pushed it back to about $1.47. The token is currently testing a critical support zone around $1.42-$1.45, which overlaps with previous resistance...
Ventripoint Diagnostics has successfully completed its annual quality and regulatory audits, including the Medical Device Single Audit Program, ISO 13485:2016, and the EU Medical Device Regulation. These audits confirm the effectiveness of Ventripoin...
